OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial
Alphonse Ouédraogo, Edith C. Bougouma, Nirianne Palacpac, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Alphonse Ouédraogo, Edith C. Bougouma, Nirianne Palacpac, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Showing 7 citing articles:
The Need for Novel Asexual Blood-Stage Malaria Vaccine Candidates for Plasmodium falciparum
Eizo Takashima, Hitoshi Otsuki, Masayuki Morita, et al.
Biomolecules (2024) Vol. 14, Iss. 1, pp. 100-100
Open Access | Times Cited: 12
Eizo Takashima, Hitoshi Otsuki, Masayuki Morita, et al.
Biomolecules (2024) Vol. 14, Iss. 1, pp. 100-100
Open Access | Times Cited: 12
Malaria vaccine efficacy, safety, and community perception in Africa: a scoping review of recent empirical studies
Muhammad Chutiyami, Priya Saravanakumar, Umar Muhammad Bello, et al.
Infection (2024) Vol. 52, Iss. 5, pp. 2007-2028
Open Access | Times Cited: 7
Muhammad Chutiyami, Priya Saravanakumar, Umar Muhammad Bello, et al.
Infection (2024) Vol. 52, Iss. 5, pp. 2007-2028
Open Access | Times Cited: 7
Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children
Hamtandi Magloire Natama, Jo Salkeld, Anyirékun Fabrice Somé, et al.
The Lancet Infectious Diseases (2024)
Open Access | Times Cited: 7
Hamtandi Magloire Natama, Jo Salkeld, Anyirékun Fabrice Somé, et al.
The Lancet Infectious Diseases (2024)
Open Access | Times Cited: 7
In vitro evaluation of multi-protein chimeric antigens in effectively clearing the blood stage of Plasmodium falciparum
Bhagyashree Deshmukh, Dhruv Khatri, Sanjay Kumar Kochar, et al.
Vaccine (2025) Vol. 53, pp. 126952-126952
Closed Access
Bhagyashree Deshmukh, Dhruv Khatri, Sanjay Kumar Kochar, et al.
Vaccine (2025) Vol. 53, pp. 126952-126952
Closed Access
Asymptomatic parasitemia and RTS,S vaccine efficacy
Nobuko Arisue, Nirianne Palacpac
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 9, pp. 942-944
Closed Access | Times Cited: 1
Nobuko Arisue, Nirianne Palacpac
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 9, pp. 942-944
Closed Access | Times Cited: 1
Immune tolerance caused by repeated P. falciparum infection against SE36 malaria vaccine candidate antigen and the resulting limited polymorphism
Nirianne Palacpac, Ken J. Ishii, Nobuko Arisue, et al.
Parasitology International (2023) Vol. 99, pp. 102845-102845
Open Access | Times Cited: 2
Nirianne Palacpac, Ken J. Ishii, Nobuko Arisue, et al.
Parasitology International (2023) Vol. 99, pp. 102845-102845
Open Access | Times Cited: 2
Persistence of Anti-SE36 Antibodies Induced by the Malaria Vaccine Candidate BK-SE36/CpG in 5–10-Year-Old Burkinabe Children Naturally Exposed to Malaria
Issa Nèbiè, Nirianne Palacpac, Edith C. Bougouma, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 166-166
Open Access
Issa Nèbiè, Nirianne Palacpac, Edith C. Bougouma, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 166-166
Open Access
